A detailed history of Two Sigma Investments, LP transactions in Hookipa Pharma Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 94,759 shares of HOOK stock, worth $60,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,759
Previous 16,016 491.65%
Holding current value
$60,645
Previous $12,000 458.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.61 - $0.83 $48,033 - $65,356
78,743 Added 491.65%
94,759 $67,000
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.86 $102,601 - $210,089
-244,290 Reduced 93.85%
16,016 $12,000
Q3 2023

Nov 14, 2023

SELL
$0.58 - $0.91 $15,775 - $24,752
-27,200 Reduced 9.46%
260,306 $161,000
Q2 2023

Aug 14, 2023

BUY
$0.71 - $1.97 $109,423 - $303,610
154,117 Added 115.54%
287,506 $253,000
Q1 2023

May 15, 2023

SELL
$0.72 - $1.03 $16,140 - $23,089
-22,417 Reduced 14.39%
133,389 $98,000
Q4 2022

Feb 14, 2023

BUY
$0.73 - $1.31 $86,090 - $154,490
117,932 Added 311.38%
155,806 $126,000
Q3 2022

Nov 14, 2022

BUY
$1.27 - $1.87 $48,099 - $70,824
37,874 New
37,874 $51,000
Q1 2022

May 16, 2022

SELL
$1.26 - $2.52 $330,389 - $660,779
-262,214 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.33 - $5.94 $176,749 - $450,596
75,858 Added 40.71%
262,214 $611,000
Q3 2021

Nov 15, 2021

BUY
$5.89 - $9.35 $913,156 - $1.45 Million
155,035 Added 494.99%
186,356 $1.1 Million
Q2 2021

Aug 16, 2021

SELL
$9.16 - $19.51 $115,333 - $245,650
-12,591 Reduced 28.67%
31,321 $287,000
Q1 2021

May 17, 2021

BUY
$10.64 - $14.7 $354,046 - $489,142
33,275 Added 312.82%
43,912 $591,000
Q4 2020

Feb 16, 2021

BUY
$9.32 - $13.63 $99,136 - $144,982
10,637 New
10,637 $118,000
Q3 2020

Nov 16, 2020

SELL
$8.59 - $11.89 $98,398 - $136,199
-11,455 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.23 - $12.1 $82,819 - $138,605
11,455 New
11,455 $133,000

Others Institutions Holding HOOK

About HOOKIPA Pharma Inc.


  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $33.1M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.